subcutaneous epcoritamab in r/r b-cell non-hodgkin lymphoma
Published 4 years ago • 1.9K plays • Length 9:41Download video MP4
Download video MP3
Similar videos
-
2:42
subcutaneous epcoritamab in r/r b-cell nhl
-
1:49
follow-up results of epcore nhl-1: subcutaneous epcoritamab in r/r lbcl
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
-
1:38
phase ii study of epcoritamab in r/r lbcl
-
1:20
subcutaneous mosunetuzumab in r/r b-cell lymphoma
-
1:00
phase ib trial of r-chop plus iberdomide or golcadomide in aggressive b-cell lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
36:13
april 10, 2024 vmr with sharmin & jack - hematuria
-
6:15
targeting ror-1 with zilovertamab in mcl and cll
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
1:06
epcore nhl-1: two and a half year follow-up of epcoritamab in dlbcl
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:27
the epoch-r clinical trial in burkitt lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
1:33
sabrina trial: subcutaneous versus intravenous rituximab for follicular lymphoma
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:35
update on phase i study of plamotamab in r/r nhl
-
1:06
pirtobrutinib in r/r mzl: insights from the bruin trial